Compounds > cyclosporine

cyclosporine and Local Neoplasm Recurrence

cyclosporine has been researched along with Local Neoplasm Recurrence in 55 studies

Research

Studies (55)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's11 (20.00)18.2507
2000's23 (41.82)29.6817
2010's11 (20.00)24.3611
2020's10 (18.18)2.80

Authors

AuthorsStudies
Bakunina, K; Broers, AEC; Cornelissen, JJ; de Groot, MR; de Jong, CN; Hazenberg, MD; Kuball, J; Meijer, E; van der Holt, B; van Gelder, M; van Marwijk Kooy, M1
Arcuri, LJ; Colares, M; da Silva, AF; da Silva, CF; de Lima, VJT; Hamerschlak, N; Kerbauy, LN; Kerbauy, MN; Lerner, D; Ribeiro, AAF1
Blosser, N; Dersch-Mills, D; Duggan, P; Ghosh, S; Jamani, K; Kwan, ACF; Leyshon, C; Puckrin, R; Savoie, L; Stewart, D; Storek, J; Zepeda, V1
Imai, H; Mitsui, A; Miyazaki, K; Nakajima, A; Noda, K; Sawaki, A; Shinoki, T; Suzuki, Y; Tawara, I; Yamamoto, Y1
Tan, K; Testro, A1
Abdel-Fattah, RM; El Gammal, MM; Elhaddad, AM; Maher, MA; Mahmoud, HK; Mansour, OM; Samra, MA; Shouman, MT1
Furlong, T; Gooley, T; Lee, SJ; Martin, PJ; Mielcarek, M; Rashid, N; Storb, R1
Defor, TE; Engle, JA; Rashidi, A; Rogosheske, J; Wasko, JA1
Fanghong, Z; Hombo, Y; Iida, H; Imada, K; Imajo, K; Kumagai, A; Maeda, T; Matsuda, A; Nakao, S; Obara, N; Tajima, T; Usuki, K1
Cai, Y; Ding, X; Huang, C; Qiu, H; Song, X; Sun, X; Tong, Y; Wan, L; Xu, X; Yang, J; Zhou, K1
Gow, PJ; Grigg, SE; Sarri, GL; Yeomans, ND1
Ishida, Y; Itokawa, T; Koyama, Y; Toyonaga, Y; Yamazaki, K1
Cai, Z; He, J; Huang, H; Lai, X; Li, L; Lin, M; Luo, Y; Shi, J; Tan, Y; Xie, W; Ye, X; Zhang, J; Zheng, W; Zhu, X1
Larkin, DF; Luthert, PJ; Manzouri, B1
Bornhäuser, M; Brendel, C; Burchert, A; Charles, J; Ellenrieder, V; Gattenlöhner, S; Hessmann, E; Inselmann, S; Metzelder, SK; Michel, C; Neubauer, A; Rehberger, M; Sohlbach, K; Solovey, M; Stiewe, T; Ten Haaf, A; von Bonin, M; Wang, Y1
Kishimoto, K; Matsuse, H; Nakayama, H; Oshio, T1
Akashi, K; Eto, T; Henzan, H; Iwasaki, H; Kamimura, T; Kato, K; Miyamoto, T; Nagafuji, K; Osaki, K; Takase, K; Takashima, S; Teshima, T; Yoshida, S; Yoshimoto, G1
Adachi, D; Hattori, N; Nakamaki, T; Nakashima, H; Saito, B; Tomoyasu, S1
Cucchetti, A; Del Gaudio, M; Grazi, GL; La Barba, G; Lauro, A; Pinna, AD; Ravaioli, M; Vivarelli, M1
Fujimoto, S; Fukuda, A; Fukudome, K; Hara, S; Iwatsubo, S; Kitamura, K; Komatsu, H; Nishiura, R; Sato, Y; Yamada, K1
Fukuhara, N; Harigae, H; Ishizawa, K; Kameoka, J; Kohata, K; Ohba-Ohtsuka, R; Ohguchi, H; Ohnishi, Y; Okitsu, Y; Tohmiya, Y; Yamada, MF; Yamamoto, J; Yokoyama, H1
Babyn, P; Chan, HS; Dimaras, H; Doyle, J; Gallie, BL; Halliday, W; Héon, E; Paton, KE; Strahlendorf, C1
Feldman, M; Griffard, EA; McCoppin, HH; Wieberg, J1
Nunez, O; Scheinberg, P; Weinstein, B; Wu, CO; Young, NS1
Hamaki, T; Kami, M; Kanda, Y; Kusumi, E; Mineishi, S; Miyakoshi, S; Momomura, S; Morinaga, S; Mutou, Y; Takaue, Y; Ueyama, J1
Aden, AA; Bellusci, R; Brillanti, S; Cavallari, A; Cavrini, G; Cucchetti, A; De Ruvo, N; La Barba, G; Vivarelli, M1
Hamazaki, Y; Hiwatashi, K; Ohguchi, H; Sai, T1
Takeshita, A1
Au, WY; Chan, GC; Ha, SY; Hon, C; Ma, SK; Wong, KF1
Carroll, M; Chow, W; Doroshow, JH; Gandara, D; Leong, L; Longmate, J; Margolin, K; McGonigle, K; Morgan, RJ; Muggia, F; Raschko, J; Reed, E; Scudder, S; Shibata, S; Somlo, G; Synold, TW; Tetef, M; Vasilev, S; Yen, Y1
Al-Ali, H; Brand, R; Deininger, M; Gentilini, C; Hegenbart, U; Krahl, R; Lange, T; Leiblein, S; Niederwieser, D; Petersdorf, E; Poenisch, W; Storb, RF; Uharek, L1
Bolondi, L; Cavallari, A; Cucchetti, A; La Barba, G; Pinna, AD; Piscaglia, F; Vivarelli, M1
Auerbach, AD; Defor, TE; Macmillan, ML; Slungaard, A; Tan, PL; Wagner, JE1
Fernández, AM; Marcén, R; Ortuño, J; Pascual, J1
Boccadoro, M; Bruno, B; Carnevale-Schianca, F; Corradini, P; Fanin, R; Giaccone, L; Guidi, S; Mattei, D; Milone, G; Montefusco, V; Patriarca, F; Peccatori, J; Petrucci, MT; Rotta, M; Sorasio, R1
Gao, CJ; Li, HH; Ning, CR; Yu, L1
Chiba, S; Izutsu, K; Kako, S; Kanda, Y; Kurokawa, M; Motokura, T; Oshima, K; Sato, H1
Ambinder, RF; Anders, V; Bolaños-Meade, J; Borrello, IM; Brodsky, R; Flinn, IW; Fuchs, EJ; Garrett-Mayer, E; Hess, AD; Huff, CA; Jones, RJ; Kasamon, YL; Luznik, L; Matsui, W; Swinnen, LJ; Vogelsang, GB; Webb, J1
Bak, T; Campsen, J; Kam, I; Skibba, A; Trotter, JF; Wachs, M; Zimmerman, MA1
Chen, H; Chen, YH; Han, W; Huang, XJ; Liu, DH; Liu, KY; Shi, HX; Wang, Y; Xu, LP1
Claudy, A; Disant, F; Dureau, G; Euvrard, S; Finaz de Villaine, J; Kanitakis, J; Pouteil-Noble, C; Thivolet, J1
Hunt, S; Johnson, F1
Bernaud, J; Garin, L; Mérieux, Y; Philippe, N; Rigal, D; Souillet, G1
Blessing, JA; Hurteau, JA; Manetta, A1
Veness, MJ1
Emre, S; Guy, SR; Kelly, DM; Miller, CM; Schwartz, ME; Sheiner, PA1
Ascher, NL; Ferrell, L; Freise, CE; Liu, T; Roberts, JP1
Bossis, S; Charlin, JF; Colin, J; Le Callonnec, A; Macarez, R; Robinet, A1
Bonetti, F; Dini, G; Giorgiani, G; Giraldi, E; Locatelli, F; Messina, C; Pession, A; Porta, F; Prete, A; Ripaldi, M; Rondelli, R; Uderzo, C; Zecca, M1
Maral, T1
Döhner, H; Gabler, A; Haas, R; Hartmann, F; Hensel, M; Ho, AD; Jung, W; Schlenk, RF; Trümper, L; Weber-Nordt, R1
Amir, G; Friedlaender, MM; Rosenbaum, E; Rubinger, D; Siguencia, E1
Chrétien, Y; Nordlinger, B; Panis, Y; Ribeiro, J1
Altomonte, V; Farmer, ER; Hess, AD; Jones, RJ; Santos, GW; Vogelsang, GB; Yeager, AM1
Ashby, M; Atkinson, K; Biggs, J; Concannon, A; Dodds, A; Downs, K; Wilson, F; Young, S1

Reviews

2 review(s) available for cyclosporine and Local Neoplasm Recurrence

ArticleYear
Systematic review with meta-analysis: sirolimus- or everolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.
    Alimentary pharmacology & therapeutics, 2019, Volume: 49, Issue:10

    Topics: Calcineurin Inhibitors; Carcinoma, Hepatocellular; Cyclosporine; Everolimus; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Neoplasm Recurrence, Local; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases

2019
[Recent advances in the treatment of acute myelogenous leukemia: a view of the new agents].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2003, Volume: 44, Issue:12

    Topics: Alkyl and Aryl Transferases; Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Benzoates; Cyclosporine; Cytarabine; Daunorubicin; Drug Design; Farnesyltranstransferase; Gemtuzumab; Humans; Leukemia, Myeloid, Acute; Neoplasm Recurrence, Local; Nucleosides; Oxides; Prognosis; Radioisotopes; Remission Induction; Tetrahydronaphthalenes; Topoisomerase Inhibitors; Tretinoin; Verapamil

2003

Trials

10 trial(s) available for cyclosporine and Local Neoplasm Recurrence

ArticleYear
Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial.
    Blood advances, 2022, 06-14, Volume: 6, Issue:11

    Topics: Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Mycophenolic Acid; Neoplasm Recurrence, Local; Prospective Studies

2022
Eltrombopag in Combination with Rabbit Anti-thymocyte Globulin/Cyclosporine A in Immunosuppressive Therapy-naïve Patients with Aplastic Anemia in Japan.
    Internal medicine (Tokyo, Japan), 2021, Apr-15, Volume: 60, Issue:8

    Topics: Anemia, Aplastic; Antilymphocyte Serum; Benzoates; Cyclosporine; Humans; Hydrazines; Immunosuppressive Agents; Japan; Neoplasm Recurrence, Local; Pyrazoles; Treatment Outcome

2021
Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia.
    Blood, 2012, Jan-12, Volume: 119, Issue:2

    Topics: Adolescent; Adult; Aged; Alemtuzumab; Anemia, Aplastic; Animals; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antilymphocyte Serum; Antineoplastic Agents; Child; Child, Preschool; Cyclosporine; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Rabbits; Salvage Therapy; Survival Rate; Treatment Outcome; Young Adult

2012
Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer.
    Cancer chemotherapy and pharmacology, 2004, Volume: 54, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclosporine; Drug Resistance, Neoplasm; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Tumor Cells, Cultured; Tumor Stem Cell Assay

2004
Bortezomib after allografting in multiple myeloma: association between neurotoxicity and cyclosporine treatment.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2007, Volume: 13, Issue:4

    Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Cyclosporine; Drug Interactions; Humans; Immunosuppressive Agents; Multiple Myeloma; Neoplasm Recurrence, Local; Peripheral Nervous System Diseases; Pyrazines; Transplantation, Homologous

2007
Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2007, Volume: 13, Issue:10

    Topics: Adult; Cyclosporine; Female; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Lymphoma, Non-Hodgkin; Male; Neoplasm Recurrence, Local; Recombinant Proteins; Salvage Therapy; Survival Analysis; Syndrome; Transplantation Conditioning; Transplantation, Autologous

2007
Evaluation of cisplatin and cyclosporin A in recurrent platinum-resistant ovarian cancer: a phase II study of the gynecologic oncology group.
    Gynecologic oncology, 1998, Volume: 68, Issue:1

    Topics: Antineoplastic Agents; Cisplatin; Cyclosporine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Neoplasm Recurrence, Local; Ovarian Neoplasms

1998
Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial.
    Blood, 2000, Mar-01, Volume: 95, Issue:5

    Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft Survival; Graft vs Host Disease; Graft vs Leukemia Effect; Histocompatibility; Humans; Immunosuppressive Agents; Infant; Italy; Leukemia; Male; Neoplasm Recurrence, Local; Nuclear Family; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Risk; Tissue Donors; Transplantation Conditioning; Treatment Outcome

2000
Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia.
    Leukemia, 2002, Volume: 16, Issue:4

    Topics: Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine

2002
A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after HLA-identical sibling marrow transplantation for haematological malignancy.
    Australian and New Zealand journal of medicine, 1991, Volume: 21, Issue:6

    Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Family; Female; Graft vs Host Disease; HLA Antigens; Humans; Incidence; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Prednisolone; Prospective Studies; Survival Analysis; Treatment Outcome

1991

Other Studies

43 other study(ies) available for cyclosporine and Local Neoplasm Recurrence

ArticleYear
Risk factors for adverse outcomes following haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide: a two-center analysis.
    Annals of hematology, 2022, Volume: 101, Issue:8

    Topics: Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Neoplasm Recurrence, Local; Prospective Studies; Retrospective Studies; Risk Factors; Tacrolimus; Transplantation Conditioning

2022
Toward optimization of cyclosporine concentration target to prevent acute graft-versus-host disease following myeloablative allogeneic stem cell transplant.
    Clinical transplantation, 2022, Volume: 36, Issue:8

    Topics: Acute Disease; Adult; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Neoplasm Recurrence, Local; Retrospective Studies; Stem Cell Transplantation; Transplantation Conditioning

2022
Subcutaneous Panniculitis-like T-cell Lymphoma with a HAVCR2 Mutation Diagnosed after 10 Years of Treatment with Glucocorticoids and Cyclosporine as Lupus Panniculitis.
    Internal medicine (Tokyo, Japan), 2023, May-15, Volume: 62, Issue:10

    Topics: Adult; Cyclosporine; Diagnosis, Differential; Glucocorticoids; Hepatitis A Virus Cellular Receptor 2; Humans; Lymphoma, T-Cell; Male; Mutation; Neoplasm Recurrence, Local; Panniculitis; Panniculitis, Lupus Erythematosus; Skin Neoplasms

2023
Cyclosporine as an alternative immunosuppressant for steroid-resistant drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
    BMJ case reports, 2023, Mar-21, Volume: 16, Issue:3

    Topics: Adrenal Cortex Hormones; Cyclosporine; Drug Hypersensitivity Syndrome; Eosinophilia; Humans; Immunosuppressive Agents; Neoplasm Recurrence, Local; Steroids

2023
Post-transplantation Cyclophosphamide-based Graft-versus-host-disease Prophylaxis Compared to Methotrexate-cyclosporine a in Matched-related Allogeneic Hematopoietic Stem Cell Transplantation.
    Hematology/oncology and stem cell therapy, 2023, May-23, Volume: 16, Issue:4

    Topics: Adult; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies

2023
Impact of Donor Statin Treatment on Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.
    Transplantation and cellular therapy, 2023, Volume: 29, Issue:11

    Topics: Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Neoplasm Recurrence, Local; Prospective Studies; Retrospective Studies; Unrelated Donors

2023
Comparison of continuous versus intermittent infusion cyclosporine and impact on transplant related outcomes in allogeneic transplant recipients.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2021, Volume: 27, Issue:8

    Topics: Adult; Allografts; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Neoplasm Recurrence, Local; Prospective Studies; Retrospective Studies

2021
Low-dose antithymocyte globulin plus low-dose posttransplant cyclophosphamide combined with cyclosporine and mycophenolate mofetil for prevention of graft-versus-host disease after HLA-matched unrelated donor peripheral blood stem cell transplantation.
    Bone marrow transplantation, 2021, Volume: 56, Issue:10

    Topics: Antilymphocyte Serum; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Mycophenolic Acid; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Transplantation Conditioning; Unrelated Donors

2021
Primary effusion lymphoma-like lymphoma unrelated to human herpesvirus 8 with aggressive clinical course in patient receiving cyclosporine.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Nov-01, Volume: 31, Issue:31

    Topics: Aged; Behcet Syndrome; Cyclosporine; Epstein-Barr Virus Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphoma; Lymphoma, Primary Effusion; Male; Neoplasm Recurrence, Local

2013
Combination of low-dose mycophenolate mofetil with cyclosporine and methotrexate as GVHD prophylaxis in unrelated donor allogeneic stem cell transplantation.
    Leukemia research, 2013, Volume: 37, Issue:9

    Topics: Adolescent; Adult; Child; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Morbidity; Mycophenolic Acid; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Transplantation, Homologous; Unrelated Donors; Young Adult

2013
Papilloma development and long-term ciclosporin use in chronic ocular allergy with associated keratoconus.
    Eye & contact lens, 2013, Volume: 39, Issue:6

    Topics: Adult; Conjunctival Neoplasms; Cyclosporine; Humans; Immunosuppressive Agents; Keratoconus; Male; Neoplasm Recurrence, Local; Papilloma

2013
NFATc1 as a therapeutic target in FLT3-ITD-positive AML.
    Leukemia, 2015, Volume: 29, Issue:7

    Topics: Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Proliferation; Cyclosporine; Drug Resistance, Neoplasm; Flow Cytometry; fms-Like Tyrosine Kinase 3; Gene Expression Profiling; Humans; Immunoenzyme Techniques; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Mutation; Neoplasm Recurrence, Local; Neoplasm Staging; NFATC Transcription Factors; Niacinamide; Oligonucleotide Array Sequence Analysis; Phenylurea Compounds; Prognosis; Protein Kinase Inhibitors; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Sorafenib; Survival Rate; Tandem Repeat Sequences; Tumor Cells, Cultured

2015
[A CASE OF PULMONARY MYCOBACTERIUM ABSCESSUS INFECTION THAT DEVELOPED DURING IMMUNOSUPPRESSIVE THERAPY FOR MYASTHENIA GRAVIS WITH RECURRENT THYMOMA].
    Kekkaku : [Tuberculosis], 2016, Volume: 91, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Levofloxacin; Male; Middle Aged; Myasthenia Gravis; Mycobacterium Infections, Nontuberculous; Neoplasm Recurrence, Local; Thymoma; Thymus Neoplasms; Treatment Outcome

2016
Comparison of cyclosporine and tacrolimus combined with mycophenolate mofetil in prophylaxis for graft-versus-host disease after reduced-intensity umbilical cord blood transplantation.
    International journal of hematology, 2017, Volume: 105, Issue:1

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Cyclosporine; Disease-Free Survival; Female; Fetal Blood; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Neoplasm Recurrence, Local; Tacrolimus; Transplantation Conditioning; Treatment Outcome

2017
Drug-induced hypersensitivity syndrome after bortezomib treatment for refractory multiple myeloma.
    Leukemia research, 2009, Volume: 33, Issue:4

    Topics: Acyclovir; Antineoplastic Agents; Antiviral Agents; Boronic Acids; Bortezomib; Cyclosporine; Dexamethasone; Drug Hypersensitivity; Exanthema Subitum; Herpesvirus 3, Human; Herpesvirus 6, Human; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Prednisone; Pyrazines; Syndrome; Virus Activation

2009
Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
    Annals of surgery, 2008, Volume: 248, Issue:5

    Topics: Adult; alpha-Fetoproteins; Calcineurin Inhibitors; Carcinoma, Hepatocellular; Cyclosporine; Female; Humans; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Risk Factors; ROC Curve; Sensitivity and Specificity; Tacrolimus

2008
[Minimal change nephrotic syndrome complicated with recurrence of malignant thymoma: an interesting case with remission due to steroid therapy of both nephrotic syndrome and thymoma].
    Nihon Jinzo Gakkai shi, 2009, Volume: 51, Issue:2

    Topics: Aged; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Male; Neoplasm Recurrence, Local; Nephrosis, Lipoid; Prednisolone; Thymoma; Thymus Neoplasms; Treatment Outcome; Vascular Endothelial Growth Factor A

2009
Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type.
    Leukemia & lymphoma, 2010, Volume: 51, Issue:8

    Topics: Adult; Antineoplastic Agents; Asparaginase; Combined Modality Therapy; Cyclosporine; Drug Resistance, Neoplasm; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphoma, T-Cell; Male; Methotrexate; Natural Killer T-Cells; Neoplasm Recurrence, Local; Nose Neoplasms; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Transplantation, Homologous; Treatment Outcome; Young Adult

2010
Multifaceted chemotherapy for trilateral retinoblastoma.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2011, Volume: 129, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cyclosporine; Cytarabine; Etoposide; Fatal Outcome; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Pineal Gland; Retinal Neoplasms; Retinoblastoma; Tomography, X-Ray Computed; Topotecan; Vincristine

2011
The cutaneous effects of post-transplant immunosuppression with cyclosporine in Muir-Torre syndrome.
    Journal of the American Academy of Dermatology, 2011, Volume: 64, Issue:5

    Topics: Adenoma, Sweat Gland; Comorbidity; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Muir-Torre Syndrome; Neoplasm Recurrence, Local; Sirolimus

2011
Sustained molecular remission in a patient with CML in blastic crisis receiving dose-reduced hematopoietic stem-cell transplantation followed by early withdrawal of cyclosporine and prophylactic use of interferon-alpha.
    American journal of hematology, 2002, Volume: 71, Issue:3

    Topics: Blast Crisis; Cyclosporine; Drug Administration Schedule; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction

2002
Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression?
    Transplantation, 2002, Dec-27, Volume: 74, Issue:12

    Topics: Adult; Carcinoma, Hepatocellular; Cyclosporine; Disease-Free Survival; Female; Humans; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Patient Selection; Postoperative Complications; Retrospective Studies; Risk Factors; Survival Rate

2002
[Cyclosporin A withdrawal causes spontaneous remission of recurrent subcutaneous tumors after allogeneic peripheral blood stem cell transplantation for adult T-cell leukemia/lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2003, Volume: 44, Issue:2

    Topics: Adult; Cyclosporine; Female; Graft vs Host Disease; Graft vs Leukemia Effect; Humans; Leukemia-Lymphoma, Adult T-Cell; Neoplasm Recurrence, Local; Neoplasm Regression, Spontaneous; Peripheral Blood Stem Cell Transplantation

2003
Bone marrow transplantation for therapy-related acute myeloid leukemia in congenital retinoblastoma associated with 13q deletion syndrome.
    Annals of hematology, 2004, Volume: 83, Issue:7

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromosome Deletion; Chromosomes, Human, Pair 13; Cryosurgery; Cryotherapy; Cyclosporine; DNA-Binding Proteins; Enzyme Inhibitors; Eye Neoplasms; Female; Histone-Lysine N-Methyltransferase; Humans; Infant, Newborn; Leukemia, Myeloid; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Peripheral Blood Stem Cell Transplantation; Proto-Oncogenes; Remission Induction; Retinoblastoma; Teniposide; Topoisomerase II Inhibitors; Transcription Factors; Vincristine

2004
BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning.
    Leukemia, 2004, Volume: 18, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclosporine; Female; Fusion Proteins, bcr-abl; Hematopoietic Stem Cell Transplantation; Hematopoietic System; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Mycophenolic Acid; Neoplasm Recurrence, Local; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Sensitivity and Specificity; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation

2004
Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2005, Volume: 11, Issue:5

    Topics: Adult; Carcinoma, Hepatocellular; Cyclosporine; Disease-Free Survival; Female; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Risk Factors; ROC Curve

2005
Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.
    Pediatric blood & cancer, 2006, May-01, Volume: 46, Issue:5

    Topics: Adolescent; Adult; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child, Preschool; Chronic Disease; Cyclophosphamide; Cyclosporine; Fanconi Anemia; Female; Fetal Blood; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Survival Rate; T-Lymphocytes; Treatment Outcome; Vidarabine

2006
Conversion to everolimus in a patient with arterial hypertension and recurrent cutaneous neoplasia--a case report.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21 Suppl 3

    Topics: Blood Pressure; Calcineurin Inhibitors; Creatinine; Cyclosporine; Drug Therapy, Combination; Everolimus; Humans; Hypertension; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Neoplasm Recurrence, Local; Postoperative Complications; Prednisolone; Sirolimus; Skin Neoplasms; Treatment Outcome; Withholding Treatment

2006
[Reversing of donor chimeras by stopping use of CsA in 2 CML patients relapsed after transplantation].
    Zhongguo shi yan xue ye xue za zhi, 2007, Volume: 15, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Graft vs Leukemia Effect; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Transplantation Chimera

2007
Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.
    American journal of hematology, 2007, Volume: 82, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cryptogenic Organizing Pneumonia; Cyclophosphamide; Cyclosporine; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Methotrexate; Neoplasm Recurrence, Local; Palatal Neoplasms; Remission Induction; Salvage Therapy; Transplantation, Homologous; Vincristine

2007
Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2008, Volume: 14, Issue:5

    Topics: Adrenal Cortex Hormones; Calcineurin Inhibitors; Carcinoma, Hepatocellular; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Diseases; Liver Failure; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Neoplasm Recurrence, Local; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Sirolimus; Tacrolimus; Time Factors; Treatment Outcome

2008
Modified donor lymphocyte infusion (DLI) for the prophylaxis of leukemia relapse after hematopoietic stem cell transplantation in patients with advanced leukemia--feasibility and safety study.
    Journal of clinical immunology, 2008, Volume: 28, Issue:4

    Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Feasibility Studies; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Leukemia; Lymphocyte Transfusion; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Tissue Donors

2008
Aggressive squamous cell carcinomas in organ transplant recipients.
    Transplantation proceedings, 1995, Volume: 27, Issue:2

    Topics: Azathioprine; Carcinoma, Squamous Cell; Cyclosporine; Heart Transplantation; Humans; Immunosuppression Therapy; Kidney Transplantation; Neoplasm Metastasis; Neoplasm Recurrence, Local; Retinoids; Retrospective Studies; Risk Factors; Skin Neoplasms

1995
Recurrent lymphoma in a cardiac allograft recipient.
    Transplantation science, 1994, Volume: 4, Issue:1

    Topics: Azathioprine; Cyclosporine; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Transplantation, Homologous

1994
Strong increase in the percentage of the CD8bright+ CD28- T-cells and delayed engraftment associated with cyclosporine-induced autologous GVHD.
    European journal of haematology, 1996, Volume: 56, Issue:3

    Topics: Autoimmune Diseases; Bone Marrow Transplantation; CD28 Antigens; Child; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukocyte Count; Male; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; T-Lymphocyte Subsets; T-Lymphocytes, Cytotoxic; Transplantation, Autologous; Treatment Outcome

1996
Cardiac transplant-related cutaneous malignancies in an Australian recipient: immunosuppression, friend or foe?
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1998, Volume: 10, Issue:3

    Topics: Adult; Australia; Azathioprine; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Glucocorticoids; Head and Neck Neoplasms; Heart Failure; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Myocardial Ischemia; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Opportunistic Infections; Prednisolone; Skin Neoplasms

1998
Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors.
    Cancer, 1998, Sep-15, Volume: 83, Issue:6

    Topics: Adult; Aged; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Retrospective Studies; Risk Assessment; Survival Analysis

1998
Effect of systemic cyclosporine on tumor recurrence after liver transplantation in a model of hepatocellular carcinoma.
    Transplantation, 1999, Feb-27, Volume: 67, Issue:4

    Topics: Animals; Cyclosporine; Disease Models, Animal; Immunosuppressive Agents; Liver Neoplasms, Experimental; Liver Transplantation; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Transplantation; Rats; Rats, Inbred ACI; Survival Rate

1999
Conjunctival epithelial neoplasias in organ transplant patients receiving cyclosporine therapy.
    Cornea, 1999, Volume: 18, Issue:4

    Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Cryosurgery; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Ophthalmologic Surgical Procedures

1999
The Koebner phenomenon in immunosuppression-related Kaposi's sarcoma.
    Annals of plastic surgery, 2000, Volume: 44, Issue:6

    Topics: Child; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney Transplantation; Neoplasm Recurrence, Local; Postoperative Complications; Sarcoma, Kaposi; Urogenital Neoplasms

2000
Temporary regression of Merkel cell carcinoma metastases after cessation of cyclosporine.
    Transplantation, 2002, Jun-15, Volume: 73, Issue:11

    Topics: Carcinoma, Merkel Cell; Cyclosporine; Fatal Outcome; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Complications; Skin Neoplasms

2002
Dormant liver metastases: an experimental study.
    The British journal of surgery, 1992, Volume: 79, Issue:3

    Topics: Animals; Cell Line; Colorectal Neoplasms; Cyclosporine; Hepatectomy; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Transplantation; Rats; Rats, Inbred Strains; Time Factors

1992
Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia.
    Blood, 1992, Jun-01, Volume: 79, Issue:11

    Topics: Adolescent; Adult; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Skin; Skin Diseases

1992